July/August 2020

Loss of smell

Through analysing new data collected through an app, Professor Sebastien Ourselin and colleagues have gained new insights into COVID-19 symptoms. 

Neutralising antibodies against SARS-CoV-2

A trio of papers describe newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV.

The great big biomedical lockdown quiz (part 2)

The second instalment of our biomedical science quiz. This time, we have four experts setting questions to test members’ knowledge across the disciplines.

Experimental cancer blood test

A new method of analysing cancer patients’ blood for evidence of the disease could be up to 10 times more sensitive than previous methods, according to new research.

COVID-19 anti-viral therapy

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

Medical eponyms part 1: Thomas Addison

This is the first article in a series of selected short biographies of persons whose names are directly used for diseases, conditions or syndromes familiar to those working in clinical pathology laboratories. 

COVID-19: a report from Melbourne, Australia

Medical Scientist Eileen Kelly reports on the impact of COVID-19 in Melbourne and the way the pandemic has been dealt with.

Detecting motor neurone disease

Scientists have identified a potential pattern within blood that signals the presence of motor neurone disease.

Infecting lab mice with SARS-CoV-2

A major hurdle to developing and testing new anti-viral therapies and vaccines for COVID-19 is the lack of good, widely available animal models of the disease. But an international team of researchers has developed a simple tool that they hope will help resolve this issue.

Editorial: the need for interaction

Sarah May, the Deputy Chief Executive of the IBMS, on the value of shared experiences.

Top